Precise magnitude of hospital markups revealed in the US
A recent study has shed light on the size of markups imposed by hospitals for parenteral cancer drugs in the US.
By
Milena Izmirlieva
Latest articles
All Articles
COVID-19 pandemic: Health system surge capacity
COVID-19, a novel coronavirus, which emerged in China in December 2019 and has since spread around the world, will…
By
Risks to UK pharmaceutical spending from a US-UK free trade deal
A leaked document about UK-US free trade deal discussions back in 2017 has dominated UK media coverage over the…
By
Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting
While attending the ISPOR Europe 2019 meeting in Copenhagen, I came across an interesting discussion of the unique challenges…
By
United States experience dramatic shift in public share of healthcare spending
Public spending on healthcare has risen dramatically in the United States from just under 50% of total healthcare spending…
By
Our pricing and reimbursement research presented at ISPOR Europe
In research, presented at the ISPOR Europe meeting in Barcelona on 13 October, Associate Director Milena Izmirlieva examines the…
By
National Academies report adds fuel to fire in raging US drug pricing debates
The National Academies of Sciences, Engineering, and Medicine have added their voice to the raging debates about drug prices…
By
What next for US healthcare reform as Senate fails to pass ACA repeal bill?
A slimmed down version of the Republican plan to repeal and replace Affordable Care Act (ACA; popularly known as…
By
The politics of oil wreak havoc on access to medicines
Recent months have seen drug shortages around the world grow worse, particularly in countries in Africa and South America…
By